Colgate-Palmolive (NYSE:CL) Shares Acquired by Maple Capital Management Inc.

Maple Capital Management Inc. boosted its holdings in Colgate-Palmolive (NYSE:CL) by 3.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 126,732 shares of the company’s stock after acquiring an additional 4,504 shares during the quarter. Maple Capital Management Inc.’s holdings in Colgate-Palmolive were worth $11,521,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in CL. SVB Wealth LLC bought a new position in Colgate-Palmolive during the 4th quarter valued at $2,782,000. Flputnam Investment Management Co. lifted its holdings in shares of Colgate-Palmolive by 1.8% in the fourth quarter. Flputnam Investment Management Co. now owns 168,367 shares of the company’s stock valued at $15,306,000 after buying an additional 3,047 shares during the period. Parkside Financial Bank & Trust boosted its stake in Colgate-Palmolive by 3.0% during the fourth quarter. Parkside Financial Bank & Trust now owns 6,673 shares of the company’s stock valued at $607,000 after buying an additional 194 shares in the last quarter. QRG Capital Management Inc. grew its holdings in Colgate-Palmolive by 2.3% during the fourth quarter. QRG Capital Management Inc. now owns 65,836 shares of the company’s stock worth $5,985,000 after acquiring an additional 1,494 shares during the period. Finally, First Command Advisory Services Inc. raised its position in Colgate-Palmolive by 8.6% in the fourth quarter. First Command Advisory Services Inc. now owns 6,489 shares of the company’s stock worth $590,000 after acquiring an additional 514 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Trading Up 1.2 %

Shares of NYSE CL opened at $91.27 on Friday. The company has a market cap of $74.07 billion, a PE ratio of 25.93, a P/E/G ratio of 4.20 and a beta of 0.44. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. Colgate-Palmolive has a 1-year low of $85.32 and a 1-year high of $109.30. The company has a 50-day moving average of $88.74 and a two-hundred day moving average of $95.51.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the previous year, the business earned $0.87 EPS. As a group, equities analysts expect that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 2.19%. The ex-dividend date of this dividend was Tuesday, January 21st. Colgate-Palmolive’s payout ratio is presently 56.82%.

Analysts Set New Price Targets

A number of brokerages have recently commented on CL. StockNews.com downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $101.00 target price on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. Morgan Stanley dropped their price target on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a research note on Monday, February 3rd. TD Cowen reduced their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. Finally, Barclays reduced their price target on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research report on Friday, January 17th. One analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $101.16.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.